Express Pharma

MAY 4, 2025

There is growing concern that a sizable proportion of medicines in India could be unsafe for patients. For example, on April 19, 2025, CDSCO published three lists of Not of Standard Quality (NSQ) drug alerts for March 2025, spanning 131 product batches. The most common reason cited is failing the dissolution test as per IP 2022. In the recent past, pharma associations as well as many individual pharma companies have clarified the differences between various terms: spurious, NSQ and counterfeits,

Packaging 66

Packaging 66

Pharmacy Joe

MAY 4, 2025

In this episode, Ill discuss thedose of inhaled tranexamic acid used for nonmassive hemoptysis. Episode 1023: The Dose of Inhaled Tranexamic Acid For Nonmassive Hemoptysis Subscribe on iTunes , Android , or Stitcher Tranexamic acid (TA) is an antifibrinolytic medication. It forms a reversible complex that displaces plasminogen from fibrin resulting in inhibition of fibrinolysis.

Inpatient 52

Inpatient Labelling Hospitals 52

Express Pharma

MAY 4, 2025

Biocon Biologics has secured multiple market access agreements for Yesintek (ustekinumab-kfce), its biosimilar to Stelara (ustekinumab). The market access agreements from numerous plans represent over 100+ million lives in the United States. Express Scripts has added Yesintek to the National Preferred Formulary (NPF) effective March 21, 2025.

Biosimilars 66

Biosimilars Immunity Immunization 66

PharmaTech

MAY 4, 2025

Commercializing a drug-device combination product is a complex challenge to handle alone. Learn how Stevanato Groups Technology Excellence Centers can provide guidance and execution through the various steps of a Validation Master Plan.

40

40

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Pharmacy Times

MAY 4, 2025

Jennifer Guthrie, RPh, district leader at CVS pharmacy describes the different medications to treat allergy symptoms and highlight how CVS stands out when addressing patients needs.

20

20

FDA Law Blog: Biosimilars

MAY 4, 2025

By Larry K. Houck Drug Enforcement Administration (DEA) civil monetary settlements involving listed chemicals that do not include pseudoephedrine are rare. Even more scarce are DEA civil settlements with non-registrants. (By my count there have been only ten since 2000). When one comes along, it is worthwhile to sit up and take notice. On March 26th the U.S.

Controlled Substances 52

Controlled Substances Packaging Labelling 52

PharmaTech

MAY 4, 2025

The release of subvisible silicone particles and the risks associated with silicone oil droplets are major factors that can compromise the safety and efficacy of sensitive drugs. Download this white paper and discover how Stevanato Group's innovative syringe platform answers this challenge.

40

40

Pharma Marketing Network

MAY 4, 2025

In todays complex landscape, pharma market research isnt just about collecting dataits about transforming that data into actionable intelligence. As 2025 unfolds, the stakes for pharmaceutical companies continue to rise. Between rapid regulatory changes, evolving HCP behavior, and digitally empowered patients, marketers are under pressure to make faster, smarter decisions.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

PharmaTech

MAY 4, 2025

Don't miss this webinar delving into: - How to streamline the selection of the primary container and delivery device - How to overcome silicone challenges in PFSs - How to enhance the delivery of highly viscous drug formulation

40

40

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Med Ed 101

MAY 4, 2025

The prescribing cascade occurs when a side effect of a medication is misinterpreted as a new medical condition, leading to the prescription of additional medicines that may be unnecessary and potentially harmful. In patients with dementia, this can be common due to polypharmacy and the complexity of managing cognitive and behavioral symptoms. Here are five […] The post Prescribing Cascade in Dementia Care – My Top 5 appeared first on Med Ed 101.

52

52

PharmaTech

MAY 4, 2025

Stevanato Groups integrated offering addressing mAbs challenges includes Aidaptus, a 2-step single-use auto-injector accommodating 1mL and 2.25mL PFSs in the same base device, supporting a range of drug viscosities for reliable delivery.

40

40

RX Note

MAY 4, 2025

[link]

40

40

PharmaTech

MAY 4, 2025

The pandemic made it daunting for companies to retain talent and then find it anew, but just as that cloud is lifting and workforce diversity is being embraced, AI beckons as a new challenge.

52

52

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Pharmacy Times

MAY 4, 2025

New trials reveal xanomeline and trospium effectively alleviate schizophrenia symptoms, offering a novel treatment option with minimal adverse effects.

29

29